Evidence map›Paper›PMID 42395146›Full record

ArticleAnnals of gastroenterological surgery2026

Impact of Recanalization on Liver Hypertrophy after Portal Vein Embolization and the Role of Re-Embolization.

Masao Uemura, Shimpei Otsuka, Ryo Ashida, Katsuhisa Ohgi, Mihoko Yamada, Rui Sato, Takeshi Aramaki, Akifumi Notsu, Katsuhiko Uesaka, Teiichi Sugiura

Abstract read
In one paragraph

Article in Annals of gastroenterological surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Masao UemuraDivision of Hepato-Biliary-Pancreatic Surgery Shizuoka Cancer Center Shizuoka Japan.
Shimpei OtsukaDivision of Hepato-Biliary-Pancreatic Surgery Shizuoka Cancer Center Shizuoka Japan.ORCID https://orcid.org/0000-0002-2450-3011
Ryo AshidaDivision of Hepato-Biliary-Pancreatic Surgery Shizuoka Cancer Center Shizuoka Japan.ORCID https://orcid.org/0000-0001-8388-0135
Katsuhisa OhgiDivision of Hepato-Biliary-Pancreatic Surgery Shizuoka Cancer Center Shizuoka Japan.
Mihoko YamadaDivision of Hepato-Biliary-Pancreatic Surgery Shizuoka Cancer Center Shizuoka Japan.
Rui SatoDivision of Interventional Radiology Shizuoka Cancer Center Shizuoka Japan.
Takeshi AramakiDivision of Interventional Radiology Shizuoka Cancer Center Shizuoka Japan.
Akifumi NotsuClinical Research Center, Shizuoka Cancer Center Shizuoka Japan.
Katsuhiko UesakaDivision of Hepato-Biliary-Pancreatic Surgery Shizuoka Cancer Center Shizuoka Japan.
Teiichi SugiuraDivision of Hepato-Biliary-Pancreatic Surgery Shizuoka Cancer Center Shizuoka Japan.ORCID https://orcid.org/0000-0001-7163-4084

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Portal vein recanalization following portal vein embolization (PVE) can impair future liver remnant (FLR) growth; however, the clinical significance of recanalization and the utility of re-embolization remain unclear. This study aimed to assess the incidence of recanalization after PVE, its impact on liver regeneration, and the efficacy of re-embolization. Methods: We retrospectively analyzed 249 consecutive patients who underwent hepatectomy following right PVE between 2010 and 2022. Recanalization was classified as major (section or segment) or minor (less than one segment). In this study, FLR was defined as the left hemiliver for standardization across different surgical procedures. Liver hypertrophy was assessed using the degree of hypertrophy (DH) and the kinetic growth rate (KGR). Re-embolization was performed in selected patients with insufficient FLR growth due to recanalization. Results: Recanalization occurred in 89 patients (36%), including 55 minor and 34 major recanalizations. DH and KGR differed significantly among the three groups. Subsequent post hoc analysis revealed that major recanalization had significantly lower DH ( Conclusions: Major recanalization after PVE was significantly associated with impaired liver regeneration. Re-embolization is a potentially effective strategy for managing insufficient FLR growth due to recanalization, particularly in cases of major recanalization.

Indexed as

future liver remnantkinetic growth rateliver hypertrophyportal vein embolizationrecanalization

Identifiers

PMID42395146
PMCPMC13326827

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.